MovDisordV3, Main, Exploration, bibRecord, 004640

Anticardiolipin antibody in vascular parkinsonism

Identifieur interne : 004640 ( Main/Exploration ); précédent : 004639; suivant : 004641

Anticardiolipin antibody in vascular parkinsonism

Auteurs : ZHIGAO HUANG [États-Unis] ; Michael Jacewicz [États-Unis] ; Ronald F. Pfeiffer [États-Unis]

Source :

Movement disorders [ 0885-3185 ] ; 2002.

RBID : Pascal:02-0584501

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Cérébrovasculaire pathologie, Diphosphatidylglycérol, Anticorps, Physiopathologie, Homme.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Antibody, Cerebrovascular disease, Diphosphatidylglycerol, Human, Parkinson disease, Pathophysiology.

Abstract

Vascular parkinsonism (VP) is characterized by predominantly lower body involvement with gait impairment and postural instability, often without tremor, and by relative levodopa unresponsiveness. Neuroimaging studies demonstrate multiple infarcts or ischemic changes in periventricular white matter. Anticardiolipin antibodies (ACLA) are associated with hypercoagulable states and increased stroke risk. Review of our Movement Disorders Clinic records identified 44 individuals with a diagnosis of VP. ACLA have been obtained in 22 of these patients (mean age, 78.3 years; mean Mini-Mental Status Exam score, 25.8). Gait disturbance was the initial clinical feature in 82% of the patients, and levodopa responsiveness was present in 18% of those treated. In 9 of the 22 (40.9%), ACLA immunoglobulin G was positive. No significant differences in clinical features or risk factors (hypertension, diabetes, coronary artery disease, and clinical stroke) were evident between ACLA+ and ACLA- groups. Since the presence of ACLA in individuals with stroke is usually treated by full-scale anticoagulation with warfarin, our findings raise the question whether such treatment should also be used in persons with VP who are ACLA positive.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 002619
to stream PascalFrancis, to step Curation: 000702
to stream PascalFrancis, to step Checkpoint: 002860
to stream Main, to step Merge: 006899
to stream Main, to step Curation: 004640

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Anticardiolipin antibody in vascular parkinsonism</title>
<author><name sortKey="Zhigao Huang" sort="Zhigao Huang" uniqKey="Zhigao Huang" last="Zhigao Huang">ZHIGAO HUANG</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, University of Tennessee Health Science Center</s1>
<s2>Memphis, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jacewicz, Michael" sort="Jacewicz, Michael" uniqKey="Jacewicz M" first="Michael" last="Jacewicz">Michael Jacewicz</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, University of Tennessee Health Science Center</s1>
<s2>Memphis, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pfeiffer, Ronald F" sort="Pfeiffer, Ronald F" uniqKey="Pfeiffer R" first="Ronald F." last="Pfeiffer">Ronald F. Pfeiffer</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, University of Tennessee Health Science Center</s1>
<s2>Memphis, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">02-0584501</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 02-0584501 INIST</idno>
<idno type="RBID">Pascal:02-0584501</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002619</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000702</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002860</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Zhigao Huang:anticardiolipin:antibody:in</idno>
<idno type="wicri:Area/Main/Merge">006899</idno>
<idno type="wicri:Area/Main/Curation">004640</idno>
<idno type="wicri:Area/Main/Exploration">004640</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Anticardiolipin antibody in vascular parkinsonism</title>
<author><name sortKey="Zhigao Huang" sort="Zhigao Huang" uniqKey="Zhigao Huang" last="Zhigao Huang">ZHIGAO HUANG</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, University of Tennessee Health Science Center</s1>
<s2>Memphis, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jacewicz, Michael" sort="Jacewicz, Michael" uniqKey="Jacewicz M" first="Michael" last="Jacewicz">Michael Jacewicz</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, University of Tennessee Health Science Center</s1>
<s2>Memphis, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pfeiffer, Ronald F" sort="Pfeiffer, Ronald F" uniqKey="Pfeiffer R" first="Ronald F." last="Pfeiffer">Ronald F. Pfeiffer</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, University of Tennessee Health Science Center</s1>
<s2>Memphis, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibody</term>
<term>Cerebrovascular disease</term>
<term>Diphosphatidylglycerol</term>
<term>Human</term>
<term>Parkinson disease</term>
<term>Pathophysiology</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Cérébrovasculaire pathologie</term>
<term>Diphosphatidylglycérol</term>
<term>Anticorps</term>
<term>Physiopathologie</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Vascular parkinsonism (VP) is characterized by predominantly lower body involvement with gait impairment and postural instability, often without tremor, and by relative levodopa unresponsiveness. Neuroimaging studies demonstrate multiple infarcts or ischemic changes in periventricular white matter. Anticardiolipin antibodies (ACLA) are associated with hypercoagulable states and increased stroke risk. Review of our Movement Disorders Clinic records identified 44 individuals with a diagnosis of VP. ACLA have been obtained in 22 of these patients (mean age, 78.3 years; mean Mini-Mental Status Exam score, 25.8). Gait disturbance was the initial clinical feature in 82% of the patients, and levodopa responsiveness was present in 18% of those treated. In 9 of the 22 (40.9%), ACLA immunoglobulin G was positive. No significant differences in clinical features or risk factors (hypertension, diabetes, coronary artery disease, and clinical stroke) were evident between ACLA+ and ACLA- groups. Since the presence of ACLA in individuals with stroke is usually treated by full-scale anticoagulation with warfarin, our findings raise the question whether such treatment should also be used in persons with VP who are ACLA positive.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Tennessee</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Tennessee"><name sortKey="Zhigao Huang" sort="Zhigao Huang" uniqKey="Zhigao Huang" last="Zhigao Huang">ZHIGAO HUANG</name>
</region>
<name sortKey="Jacewicz, Michael" sort="Jacewicz, Michael" uniqKey="Jacewicz M" first="Michael" last="Jacewicz">Michael Jacewicz</name>
<name sortKey="Pfeiffer, Ronald F" sort="Pfeiffer, Ronald F" uniqKey="Pfeiffer R" first="Ronald F." last="Pfeiffer">Ronald F. Pfeiffer</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004640 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004640 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:02-0584501
   |texte=   Anticardiolipin antibody in vascular parkinsonism
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Anticardiolipin antibody in vascular parkinsonism

Anticardiolipin antibody in vascular parkinsonism

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri